Correlation Between Bioventus and Bone Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bioventus and Bone Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bioventus and Bone Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bioventus and Bone Biologics Corp, you can compare the effects of market volatilities on Bioventus and Bone Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bioventus with a short position of Bone Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bioventus and Bone Biologics.

Diversification Opportunities for Bioventus and Bone Biologics

0.25
  Correlation Coefficient

Modest diversification

The 3 months correlation between Bioventus and Bone is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Bioventus and Bone Biologics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bone Biologics Corp and Bioventus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bioventus are associated (or correlated) with Bone Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bone Biologics Corp has no effect on the direction of Bioventus i.e., Bioventus and Bone Biologics go up and down completely randomly.

Pair Corralation between Bioventus and Bone Biologics

Considering the 90-day investment horizon Bioventus is expected to generate 0.66 times more return on investment than Bone Biologics. However, Bioventus is 1.51 times less risky than Bone Biologics. It trades about -0.11 of its potential returns per unit of risk. Bone Biologics Corp is currently generating about -0.16 per unit of risk. If you would invest  1,306  in Bioventus on August 28, 2024 and sell it today you would lose (156.00) from holding Bioventus or give up 11.94% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Bioventus  vs.  Bone Biologics Corp

 Performance 
       Timeline  
Bioventus 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Bioventus are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Bioventus unveiled solid returns over the last few months and may actually be approaching a breakup point.
Bone Biologics Corp 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Bone Biologics Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak essential indicators, Bone Biologics reported solid returns over the last few months and may actually be approaching a breakup point.

Bioventus and Bone Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bioventus and Bone Biologics

The main advantage of trading using opposite Bioventus and Bone Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bioventus position performs unexpectedly, Bone Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bone Biologics will offset losses from the drop in Bone Biologics' long position.
The idea behind Bioventus and Bone Biologics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.